Literature DB >> 15964428

Anti-Wolbachia treatment for lymphatic filariasis.

Wilma A Stolk1, Sake J de Vlas, J Dik F Habbema.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964428     DOI: 10.1016/S0140-6736(05)66714-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

2.  Wolbachia in filarial parasites: targets for filarial infection and disease control.

Authors:  Kelly L Johnston; Mark J Taylor
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

Review 3.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

4.  Molecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme.

Authors:  Ajay Kumar Rana; Sharat Chandra; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

5.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30

6.  Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.

Authors:  Wilma A Stolk; Sake J de Vlas; J Dik F Habbema
Journal:  Filaria J       Date:  2006-03-28

7.  The untapped cell biology of neglected tropical diseases.

Authors:  William Sullivan
Journal:  Mol Biol Cell       Date:  2016-03-01       Impact factor: 4.138

8.  Antifilarial and Antibiotic Activities of Methanolic Extracts of Melaleuca cajuputi Flowers.

Authors:  Nazeh M Al-Abd; Zurainee Mohamed Nor; Marzida Mansor; M S Hasan; Mustafa Kassim
Journal:  Korean J Parasitol       Date:  2016-06-30       Impact factor: 1.341

9.  Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

Authors:  Wilma A Stolk; Quirine A ten Bosch; Sake J de Vlas; Peter U Fischer; Gary J Weil; Ann S Goldman
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03

10.  Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.

Authors:  Purushothaman Jambulingam; Swaminathan Subramanian; S J de Vlas; Chellasamy Vinubala; W A Stolk
Journal:  Parasit Vectors       Date:  2016-09-13       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.